Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer
- 1 September 2001
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (1), 41-48
- https://doi.org/10.1016/s0360-3016(01)01594-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Five-year biochemical outcome after prostate brachytherapy for hormone-naive men ≤ 62 years of ageInternational Journal of Radiation Oncology*Biology*Physics, 2001
- SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUESJournal of Urology, 2000
- Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Modern prostate brachytherapyCancer, 2000
- Palladium-103 brachytherapy for prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Comparison of seed loading approaches in prostate brachytherapyMedical Physics, 2000
- Seed fixity in the prostate/periprostatic region following brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995